Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOW-PROMOTE: Intensive lipid lowering and CT-derived FFR in stable chest pain
2019-001912-50Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ezetimibe, atorvastatin and rosuvastatin in coronary arteriosclerosis (2 arms), sponsored by Aarhus University Hospital. Started Jul 2019; status: completed.
02
Drugs
ezetimibeatorvastatinrosuvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2019-001912-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001912-50.